DOI: 10.1128/mSphere.00314-20
Article Information
PubMed
Published By
History
- Received April 9, 2020
- Accepted September 20, 2020
- Published online October 21, 2020.
Copyright & Usage
Copyright © 2020 Kang et al. This is an open-access article distributed under the terms of the Creative Commons Attribution 4.0 International license.
Editors and / or Reviewers
- Maria L. Marco, Editor, University of California, Davis
Author Information
- Dae-Wook Kanga*,
- James B. Adamsb,
- Troy Vargasonc,d,
- Marina Santiagoe,
- Juergen Hahnc,d,f and
- Rosa Krajmalnik-Browna,g,h
- aBiodesign Swette Center for Environmental Biotechnology, Arizona State University, Tempe, Arizona, USA
- bSchool for Engineering of Matter, Transport and Energy, Arizona State University, Tempe, Arizona, USA
- cDepartment of Biomedical Engineering, Rensselaer Polytechnic Institute, Troy, New York, USA
- dCenter for Biotechnology and Interdisciplinary Studies, Rensselaer Polytechnic Institute, Troy, New York, USA
- eFinch Therapeutics, Somerville, Massachusetts, USA
- fDepartment of Chemical and Biological Engineering, Rensselaer Polytechnic Institute, Troy, New York, USA
- gSchool of Sustainable Engineering and the Built Environment, Arizona State University, Tempe, Arizona, USA
- hBiodesign Center for Health Through Microbiomes, Arizona State University, Tempe, Arizona, USA
- Address correspondence to Dae-Wook Kang, daewook.kang{at}utoledo.edu, or Rosa Krajmalnik-Brown, Dr.Rosy{at}asu.edu.
↵* Present address: Dae-Wook Kang, Department of Civil and Environmental Engineering, The University of Toledo, Toledo, Ohio, USA.
Citation Kang D-W, Adams JB, Vargason T, Santiago M, Hahn J, Krajmalnik-Brown R. 2020. Distinct fecal and plasma metabolites in children with autism spectrum disorders and their modulation after microbiota transfer therapy. mSphere 5:e00314-20. https://doi.org/10.1128/mSphere.00314-20.
